Blog
SGLT2 Inhibitors and Liver Cirrhosis
The article titled "Therapeutic Potential of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Liver Disease: Focus on Cirrhosis" explores the emerging role of SGLT2 inhibitors beyond their established use in managing type 2 diabetes mellitus (T2DM). It delves into...
MASLD Tied to Increased Preterm Birth Risk
“This nationwide study of pregnant women with MASLD confirms that MASLD should be regarded as a high-risk obstetric condition, carrying significant implications for pregnancy care,” the authors write. “Reassuringly, MASLD was not associated with abnormal birth weight...
Hepatitis C
From the great folks at HepVu, including how to get tested-- About HepVu An estimated 4 million people in the U.S. are living with Hepatitis C infection. Making data on the viral hepatitis epidemic widely available, easily accessible, and locally relevant to...
